Drug

Episalvan clinical trials

Also written AP-101.

studies test it: 11
open now: 1
in phase 3: 5
first study started: 2008

Keep track of what changes. Save the episalvan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

11 studies that test it; most in 2010 (2)

Studies that test episalvan, by start year
Year	Studies
2008	1
2010	2
2012	2
2013	1
2017	1
2019	1
2021	2
2025	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 5
Phase 3: 5

What it is tested for

Each study’s main condition, where its own words name it.

Amyotrophic Lateral Sclerosis: 2
Epidermolysis Bullosa: 2
Breast Neoplasms: 1
Burns: 1
Keratosis, Actinic: 1
Epidermolysis Bullosa Dystrophica: 1

Who runs them

Industry 10 · Other 1

Birken AG (6) · AL-S Pharma (2) · Memorial Sloan Kettering Cancer Center (1) · Amryt Research Limited (1) · Chiesi Farmaceutici S.p.A. (1)

Often tested with

Tested in the same studies.

Birch triterpenes (7)

Studies

Open first, then newest update. How each study uses episalvan is read from its arms, and is right about nine times in ten.

Episalvan clinical trials

How studies write it

Name

Development codes

Combined with it in one product